$23.46 – $63.35
B7-33 Pre-Mixed Peptide 2mg
Recent laboratory research has revealed the following benefits of B7-33:
SAVE 10% when buying 3 cartridges.
494 in stock
Save 10%
B7-33 pre-mixed peptide is a single-chain peptide derived from H2-relaxin, a crucial water-soluble protein. Despite lacking cAMP activity and synthesis, B7-33 retains its sedative properties while triggering ERK1/2 phosphorylation, thus enhancing MMP2 synthesis and collagen degradation.
Within the relaxin protein family, notable members include relaxin, insulin-like peptide 3, H3-relaxin, and insulin-like peptide 5.
Insulin-related proteins have been extensively studied, revealing noteworthy musculoskeletal, cardiovascular, and reproductive effects.
Ground breaking research in animal studies demonstrates the numerous benefits of B7-33 pre-mixed peptide, including its potential to reduce heart damage and fibrinolysis in both acute and chronic diseases. Furthermore, it exhibits promising capabilities in treating vascular diseases and preventing cardiac injury-related scarring.
Reducing inflammation and wound healing qualities.
Relaxin receptors have various functions beyond just activating cAMP. In addition to corticotropin-releasing factor (CRF), insulin-like peptides can also interact with these receptors.
Research and data analysis show that these activators have anti-inflammatory, antioxidative, and wound-healing effects. Consequently, Relaxin has become the main ligand for these receptors. Additionally, these agents display impressive anti-fibrotic properties.
Research using animal models has revealed Relaxin as an interesting vasodilator, blood vessel stimulant, and antihypertensive agent. Its various functions give Relaxin strong anti-fibrotic properties, prompting further investigation into its potential use for acute heart failure and other fibrotic conditions.
Reduction of Scar Tissue
After heart damage, clinical trials have shown that the B7-33 Peptide can reduce excessive scar tissue formation. Additionally, it shows promise in treating long-term vascular diseases and preeclampsia during pregnancy.
Decreased fibrosis
B7-33 has strong anti-fibrotic properties, making it an interesting topic for research on conditions such as heart failure, lung inflammation, and kidney disease. Recent studies have shown promising results in using the B7-33 peptide to treat heart failure in animals, leading to longer survival after injury and improved overall health.
There is also the option Sweden to buy B7-33 Nasal Spray and B7-33 Peptide Vial.
[1] https://pubmed.ncbi.nlm.nih.gov/ 32295457/
[2] https://pubmed.ncbi.nlm.nih.gov/28478069/
Sequence: VIKLSGRELVRAQIAISGMSTWSKRSL
ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.
DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our Sweden Direct Sarms website is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.
All pre-mixed cartridges are mixed with 2ml bacteriostatic water, pens will release approximately 0.5ml per 60 dials on the pen (one full pen)
To achieve the number of micrograms (mcg) that 1 dial on the pen will release you will need to simply divide the amount of product:
2mg = 2000mcg
5mg = 5000mcg
by the full amount of pen dials (which will always be 240)
E.g., 5000mcg divided by 240 = 20.83, therefore 1 dial on the pen for all 5mg products will release approximately 20.83mcg.
Save 10%
Worldwide
shipping
Visa/Mastercard/Zelle
Cryptocurrency /Transfers
Safe and Secure Shopping
We Distribute
From
YOU MUST BE OVER 21 YEARS IN ORDER TO USE THIS WEBSITE. All of the products are to be handled only by properly trained and qualified LABORATORY or RESEARCH professionals.